KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomarin Pharmaceutical (BMRN) Revenue: 2009-2024

Historic Revenue for Biomarin Pharmaceutical (BMRN) over the last 16 years, with Dec 2024 value amounting to $2.9 billion.

  • Biomarin Pharmaceutical's Revenue rose 4.08% to $776.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year increase of 12.39%. This contributed to the annual value of $2.9 billion for FY2024, which is 17.97% up from last year.
  • According to the latest figures from FY2024, Biomarin Pharmaceutical's Revenue is $2.9 billion, which was up 17.97% from $2.4 billion recorded in FY2023.
  • Biomarin Pharmaceutical's 5-year Revenue high stood at $2.9 billion for FY2024, and its period low was $1.8 billion during FY2021.
  • In the last 3 years, Biomarin Pharmaceutical's Revenue had a median value of $2.4 billion in 2023 and averaged $2.5 billion.
  • In the last 5 years, Biomarin Pharmaceutical's Revenue decreased by 0.76% in 2021 and then grew by 17.97% in 2024.
  • Biomarin Pharmaceutical's Revenue (Yearly) stood at $1.9 billion in 2020, then decreased by 0.76% to $1.8 billion in 2021, then climbed by 13.53% to $2.1 billion in 2022, then grew by 15.42% to $2.4 billion in 2023, then increased by 17.97% to $2.9 billion in 2024.